Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 790-801
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Examining the interim proposal for name change to steatotic liver disease in the US population
Cheng Han Ng, Kai En Chan, Mark Muthiah, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1712-1721
Closed Access | Times Cited: 10
A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population
Chih-Yi Ho, Jia‐In Lee, Shu‐Pin Huang, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 77-77
Open Access | Times Cited: 9
Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction
Hee Jun Park, Sunyoung Lee, Jae Seung Lee
Abdominal Radiology (2024) Vol. 49, Iss. 9, pp. 3036-3044
Closed Access | Times Cited: 3
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
Muhammed Mubarak
World Journal of Gastrointestinal Pathophysiology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 9, pp. 1598-1609
Closed Access | Times Cited: 7
Integrative insights into cerebrometabolic disease: Understanding, management, and future prospects
Gaili Yan, Xiangyu Zhang, Yang Liu, et al.
Journal of Neurorestoratology (2024) Vol. 12, Iss. 2, pp. 100107-100107
Open Access | Times Cited: 2
Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1
Chaoyuan Huang, Qiuhong Yong, Yi‐Hui Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Association between flavonoid and subclasses intake and metabolic associated fatty liver disease in U.S. adults: Results from National Health and Nutrition Examination Survey 2017–2018
Junlu Tong, Yingjuan Zeng, Jianhui Xie, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
The growing burden of non-alcoholic fatty liver disease on mortality
Ju‐Yeon Cho, Won Sohn
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 374-376
Open Access | Times Cited: 6
Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, et al.
ULTRASONOGRAPHY (2023) Vol. 42, Iss. 3, pp. 421-431
Open Access | Times Cited: 6
Global Leadership Initiative on Malnutrition-defined malnutrition coexisting with visceral adiposity predicted worse long-term all-cause mortality among inpatients with decompensated cirrhosis
Han Wang, Tianming Zhao, Gaoyue Guo, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
A nonlinear relationship between dietary inflammatory index and stroke among US adults with metabolic dysfunction-associated steatotic liver disease
Renwei Guo, Juan Du
European Journal of Gastroenterology & Hepatology (2024) Vol. 37, Iss. 3, pp. 272-278
Closed Access | Times Cited: 1
Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES
Jiaxin Dong, Lili Jiang, Yanpeng Liu, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children
María-Luisa Lazo-de-la-Vega-Monroy, Monica-del-Carmen Preciado-Puga, Yeniley Ruíz‐Noa, et al.
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 47, Iss. 6, pp. 102137-102137
Closed Access | Times Cited: 4
The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study
Xinyu Wang, Shuhang Wei, Yingnan Wei, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 8, pp. 889-898
Closed Access | Times Cited: 4
Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, et al.
Gut and Liver (2023) Vol. 18, Iss. 2, pp. 283-293
Open Access | Times Cited: 4
Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis
Ziming Yang, Li Zhang, Jinlei Liu, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1848-1848
Open Access | Times Cited: 4
Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease
Ya Wang, Wanhan Song, Qianhua Yuan, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 4, pp. 469-479
Closed Access | Times Cited: 4
The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
George Chen, Bubu A. Banini, Albert Do, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S319-S332
Open Access | Times Cited: 7
Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China
Mingxing Chang, Zhihao Shao, Wei Wei, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Nonlinear relationship between the triglyceride–glucose index and alanine aminotransferase in children with short stature
Qianqian Zhao, Youqian Li, Mei Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Evaluation of Uttroside B, a potent bioactive from Solanum nigrum Linn, as a candidate drug molecule against non-alcoholic fatty liver disease
Rayginia P Tennyson, Chenicheri K. Keerthana, Sadiq C. Shifana, et al.
Biomedicine (2024) Vol. 44, Iss. 1, pp. 65-70
Open Access
Gender differences in aging rates among patients with non-alcoholic fatty liver disease
Olena Kolesnikova, A. O. Radchenko, O. E. Zaprovalna
Modern Gastroenterology (2023), Iss. 3, pp. 5-13
Open Access | Times Cited: 1
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Young‐Joo Jin
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 414-416
Open Access | Times Cited: 1
Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity
Jung Gil Park
Gut and Liver (2023) Vol. 17, Iss. 4, pp. 489-490
Open Access | Times Cited: 1

Scroll to top